Search research articles
Contact Us
Filters
Showing results (51-60 of 107) with videos related to
Page
of 11
Sort By:
International Journal of Environmental Research and Public Health
|
January 11, 2022
Planning for Implementation Success of an Electronic Cross-Facility Health Record for Pediatric Palliative Care Using the Consolidated Framework for Implementation Research (CFIR)
Theresa Sophie Busse, Sven Kernebeck, Larissa Alice Dreier, et al.
Arthritis Research & Therapy
|
April 17, 2021
Re-treatment with etanercept is as effective as the initial firstline treatment in patients with juvenile idiopathic arthritis
Jens Klotsche, Ariane Klein, Martina Niewerth, et al.
Healthcare (Basel, Switzerland)
|
August 12, 2023
Evaluation of a Webinar to Increase Health Professionals' Knowledge about Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Laura Froehlich, Jasmin Niedrich, Daniel B R Hattesohl, et al.
Modern Rheumatology
|
July 9, 2016
Incidence of malignancies in patients with juvenile idiopathic arthritis: A retrospective single-center cohort study in Germany
Swaantje Barth, Jenny Schlichtiger, Barbara Hartmann, et al.
The Journal of Rheumatology
|
December 7, 2005
Extravasation into synovial tissue induces CCL20 mRNA expression in polymorphonuclear neutrophils of patients with rheumatoid arthritis
Judith Schlenk, Hanns-Martin Lorenz, Johannes-Peter Haas, et al.
RMD Open
|
December 22, 2015
The majority of newly diagnosed patients with juvenile idiopathic arthritis reach an inactive disease state within the first year of specialised care: data from a German inception cohort
Claudia Sengler, Jens Klotsche, Martina Niewerth, et al.
Arthritis Research & Therapy
|
June 1, 2018
Transcription factor motif enrichment in whole transcriptome analysis identifies STAT4 and BCL6 as the most prominent binding motif in systemic juvenile idiopathic arthritis
Boris Hügle, Anastasia Schippers, Nadine Fischer, et al.
Arthritis Research & Therapy
|
November 25, 2016
Comparison of treatment response, remission rate and drug adherence in polyarticular juvenile idiopathic arthritis patients treated with etanercept, adalimumab or tocilizumab
Gerd Horneff, Ariane Klein, Jens Klotsche, et al.
Paediatric and Perinatal Epidemiology
|
April 27, 2010
Survey of Neonates in Pomerania (SNiP): a population-based birth study--objectives, design and population coverage
Arno Ebner, Jochen R Thyrian, Anja Lange, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
October 11, 2019
Impact of IL1RN Variants on Response to Interleukin-1 Blocking Therapy in Systemic Juvenile Idiopathic Arthritis
Claas Hinze, Sabrina Fuehner, Christoph Kessel, et al.
Page
of 11
Search research articles
Search
Showing results (51-60 of 107) with videos related to
Sort By:
Page
of 11
International Journal of Environmental Research and Public Health
|
January 11, 2022
Planning for Implementation Success of an Electronic Cross-Facility Health Record for Pediatric Palliative Care Using the Consolidated Framework for Implementation Research (CFIR)
Theresa Sophie Busse, Sven Kernebeck, Larissa Alice Dreier, et al.
Arthritis Research & Therapy
|
April 17, 2021
Re-treatment with etanercept is as effective as the initial firstline treatment in patients with juvenile idiopathic arthritis
Jens Klotsche, Ariane Klein, Martina Niewerth, et al.
Healthcare (Basel, Switzerland)
|
August 12, 2023
Evaluation of a Webinar to Increase Health Professionals' Knowledge about Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Laura Froehlich, Jasmin Niedrich, Daniel B R Hattesohl, et al.
Modern Rheumatology
|
July 9, 2016
Incidence of malignancies in patients with juvenile idiopathic arthritis: A retrospective single-center cohort study in Germany
Swaantje Barth, Jenny Schlichtiger, Barbara Hartmann, et al.
The Journal of Rheumatology
|
December 7, 2005
Extravasation into synovial tissue induces CCL20 mRNA expression in polymorphonuclear neutrophils of patients with rheumatoid arthritis
Judith Schlenk, Hanns-Martin Lorenz, Johannes-Peter Haas, et al.
RMD Open
|
December 22, 2015
The majority of newly diagnosed patients with juvenile idiopathic arthritis reach an inactive disease state within the first year of specialised care: data from a German inception cohort
Claudia Sengler, Jens Klotsche, Martina Niewerth, et al.
Arthritis Research & Therapy
|
June 1, 2018
Transcription factor motif enrichment in whole transcriptome analysis identifies STAT4 and BCL6 as the most prominent binding motif in systemic juvenile idiopathic arthritis
Boris Hügle, Anastasia Schippers, Nadine Fischer, et al.
Arthritis Research & Therapy
|
November 25, 2016
Comparison of treatment response, remission rate and drug adherence in polyarticular juvenile idiopathic arthritis patients treated with etanercept, adalimumab or tocilizumab
Gerd Horneff, Ariane Klein, Jens Klotsche, et al.
Paediatric and Perinatal Epidemiology
|
April 27, 2010
Survey of Neonates in Pomerania (SNiP): a population-based birth study--objectives, design and population coverage
Arno Ebner, Jochen R Thyrian, Anja Lange, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
October 11, 2019
Impact of IL1RN Variants on Response to Interleukin-1 Blocking Therapy in Systemic Juvenile Idiopathic Arthritis
Claas Hinze, Sabrina Fuehner, Christoph Kessel, et al.
Page
of 11